Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature.

Visser M, Paulus WJ, Vermeulen MA, Richir MC, Davids M, Wisselink W, de Mol BA, van Leeuwen PA.

Eur J Heart Fail. 2010 Dec;12(12):1274-81. doi: 10.1093/eurjhf/hfq158. Epub 2010 Oct 5. Review.

2.

The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function.

Richir MC, Bouwman RH, Teerlink T, Siroen MP, de Vries TP, van Leeuwen PA.

JPEN J Parenter Enteral Nutr. 2008 Nov-Dec;32(6):613-21. doi: 10.1177/0148607108321702. Review.

PMID:
18974239
3.

Effect of asymmetric dimethylarginine (ADMA) on heart failure development.

Liu X, Hou L, Xu D, Chen A, Yang L, Zhuang Y, Xu Y, Fassett JT, Chen Y.

Nitric Oxide. 2016 Apr 1;54:73-81. doi: 10.1016/j.niox.2016.02.006. Epub 2016 Feb 24. Review.

4.
5.

Dimethylarginine dimethylaminohydrolase regulation: a novel therapeutic target in cardiovascular disease.

Wadham C, Mangoni AA.

Expert Opin Drug Metab Toxicol. 2009 Mar;5(3):303-19. doi: 10.1517/17425250902785172 . Review.

PMID:
19331593
6.

Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.

Palm F, Onozato ML, Luo Z, Wilcox CS.

Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3227-45. Epub 2007 Oct 12. Review.

7.

The DDAH/ADMA/NOS pathway.

Tran CT, Leiper JM, Vallance P.

Atheroscler Suppl. 2003 Dec;4(4):33-40. Review.

PMID:
14664901
8.

The biology and therapeutic potential of the DDAH/ADMA pathway.

Arrigoni F, Ahmetaj B, Leiper J.

Curr Pharm Des. 2010;16(37):4089-102. Review.

PMID:
21247398
9.

Arginine, arginine analogs and nitric oxide production in chronic kidney disease.

Baylis C.

Nat Clin Pract Nephrol. 2006 Apr;2(4):209-20. Review.

10.

The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis.

Leiper J, Nandi M.

Nat Rev Drug Discov. 2011 Apr;10(4):277-91. doi: 10.1038/nrd3358. Review.

PMID:
21455237
11.

Asymmetric dimethylarginine, endothelial dysfunction and renal disease.

Aldámiz-Echevarría L, Andrade F.

Int J Mol Sci. 2012;13(9):11288-311. doi: 10.3390/ijms130911288. Epub 2012 Sep 10. Review.

12.

Asymmetric dimethylarginine and critical illness.

Brinkmann SJ, de Boer MC, Buijs N, van Leeuwen PA.

Curr Opin Clin Nutr Metab Care. 2014 Jan;17(1):90-7. doi: 10.1097/MCO.0000000000000020. Review.

PMID:
24281375
13.

Role of asymmetric dimethylarginine (ADMA) in diabetic vascular complications.

Yamagishi S, Ueda S, Nakamura K, Matsui T, Okuda S.

Curr Pharm Des. 2008;14(25):2613-8. Review.

PMID:
18991678
14.

The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor.

Böger RH.

Cardiovasc Res. 2003 Oct 1;59(4):824-33. Review.

PMID:
14553822
15.

The endothelial ADMA/NO pathway in hypoxia-related chronic respiratory diseases.

Lüneburg N, Harbaum L, Hennigs JK.

Biomed Res Int. 2014;2014:501612. doi: 10.1155/2014/501612. Epub 2014 Feb 25. Review.

16.

Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway.

Vallance P, Leiper J.

Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):1023-30. Epub 2004 Apr 22. Review.

17.

Endogenous inhibitors of nitric oxide and preeclampsia: a review.

Slaghekke F, Dekker G, Jeffries B.

J Matern Fetal Neonatal Med. 2006 Aug;19(8):447-52. Review.

PMID:
16966108
18.

Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism.

Wilcken DE, Sim AS, Wang J, Wang XL.

Mol Genet Metab. 2007 Aug;91(4):309-17; discussion 308. Epub 2007 Jun 7. Review.

PMID:
17560156
19.

Asymmetric Dimethylarginine (ADMA): a promising biomarker for cardiovascular disease?

Bouras G, Deftereos S, Tousoulis D, Giannopoulos G, Chatzis G, Tsounis D, Cleman MW, Stefanadis C.

Curr Top Med Chem. 2013;13(2):180-200. Review.

PMID:
23470077
20.

The DDAH/ADMA pathway in the control of endothelial cell migration and angiogenesis.

Fiedler LR, Wojciak-Stothard B.

Biochem Soc Trans. 2009 Dec;37(Pt 6):1243-7. doi: 10.1042/BST0371243. Review.

PMID:
19909255

Supplemental Content

Support Center